These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17473191)

  • 1. Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness.
    Kader AK; Liu J; Shao L; Dinney CP; Lin J; Wang Y; Gu J; Grossman HB; Wu X
    Clin Cancer Res; 2007 May; 13(9):2614-20. PubMed ID: 17473191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.
    Chen M; Kamat AM; Huang M; Grossman HB; Dinney CP; Lerner SP; Wu X; Gu J
    Carcinogenesis; 2007 Oct; 28(10):2160-5. PubMed ID: 17728339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
    Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
    Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
    Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
    Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
    Woo M; Park K; Nam J; Kim JC
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression.
    Sun T; Gao Y; Tan W; Ma S; Zhang X; Wang Y; Zhang Q; Guo Y; Zhao D; Zeng C; Lin D
    Clin Cancer Res; 2006 Dec; 12(23):7009-17. PubMed ID: 17145822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
    Su L; Zhou W; Asomaning K; Lin X; Wain JC; Lynch TJ; Liu G; Christiani DC
    Carcinogenesis; 2006 May; 27(5):1024-9. PubMed ID: 16311244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
    Hughes S; Agbaje O; Bowen RL; Holliday DL; Shaw JA; Duffy S; Jones JL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6673-80. PubMed ID: 18006768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
    Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR
    J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
    J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression.
    Borghese B; Chiche JD; Vernerey D; Chenot C; Mir O; Bijaoui G; Bonaiti-Pellié C; Chapron C
    Hum Reprod; 2008 May; 23(5):1207-13. PubMed ID: 18308831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.
    Heist RS; Marshall AL; Liu G; Zhou W; Su L; Neuberg D; Lynch TJ; Wain J; Christiani DC
    Clin Cancer Res; 2006 Sep; 12(18):5448-53. PubMed ID: 17000679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
    Yang H; Gu J; Lin X; Grossman HB; Ye Y; Dinney CP; Wu X
    Clin Cancer Res; 2008 Apr; 14(7):2236-44. PubMed ID: 18381966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
    Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
    Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.
    Wieczorek E; Reszka E; Jablonowski Z; Jablonska E; Krol MB; Grzegorczyk A; Gromadzinska J; Sosnowski M; Wasowicz W
    BJU Int; 2013 Dec; 112(8):1207-14. PubMed ID: 23819551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: a mini-review.
    Wieczorek E; Wasowicz W; Gromadzinska J; Reszka E
    Int J Urol; 2014 Aug; 21(8):744-52. PubMed ID: 24635493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.